Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice
Elaine Wan, … , Hasan Garan, Steven O. Marx
Elaine Wan, … , Hasan Garan, Steven O. Marx
Published November 23, 2015
Citation Information: J Clin Invest. 2016;126(1):112-122. https://doi.org/10.1172/JCI84669.
View: Text | PDF
Technical Advance Cardiology

Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice

  • Text
  • PDF
Abstract

Increased sodium influx via incomplete inactivation of the major cardiac sodium channel NaV1.5 is correlated with an increased incidence of atrial fibrillation (AF) in humans. Here, we sought to determine whether increased sodium entry is sufficient to cause the structural and electrophysiological perturbations that are required to initiate and sustain AF. We used mice expressing a human NaV1.5 variant with a mutation in the anesthetic-binding site (F1759A-NaV1.5) and demonstrated that incomplete Na+ channel inactivation is sufficient to drive structural alterations, including atrial and ventricular enlargement, myofibril disarray, fibrosis and mitochondrial injury, and electrophysiological dysfunctions that together lead to spontaneous and prolonged episodes of AF in these mice. Using this model, we determined that the increase in a persistent sodium current causes heterogeneously prolonged action potential duration and rotors, as well as wave and wavelets in the atria, and thereby mimics mechanistic theories that have been proposed for AF in humans. Acute inhibition of the sodium-calcium exchanger, which targets the downstream effects of enhanced sodium entry, markedly reduced the burden of AF and ventricular arrhythmias in this model, suggesting a potential therapeutic approach for AF. Together, our results indicate that these mice will be important for assessing the cellular mechanisms and potential effectiveness of antiarrhythmic therapies.

Authors

Elaine Wan, Jeffrey Abrams, Richard L. Weinberg, Alexander N. Katchman, Joseph Bayne, Sergey I. Zakharov, Lin Yang, John P. Morrow, Hasan Garan, Steven O. Marx

×

Figure 1

Cardiac-specific, FLAG-tagged F1759A-NaV1.5–expressing TG mice.

Options: View larger image (or click on image) Download as PowerPoint
Cardiac-specific, FLAG-tagged F1759A-NaV1.5–expressing TG mice.
(A) Sche...
(A) Schematic of the binary transgene system. αMHC-rtTA is the standard cardiac-specific, reverse tetracycline–controlled transactivator system. The αMHCMOD construct is a modified αMHC promoter containing the tet-operon (tet-O) for regulated expression of FLAG-tagged, lidocaine-resistant NaV1.5 (FLAG-lido-NaV). (B) Quantification of mouse Scn5a and human SCN5A transcripts in ventricle and atrium of F1759A-dTG mice using qPCR. Results are presented as fold difference for each gene against actin by use of 2–ΔΔCT method, followed by normalization to expression of either mouse Scn5a or mouse Scn5a and human SCN5A determined in NTG mice. n = 3 NTG and n = 4 F1759A-dTG mice in each group. (C) Immunostaining of F1759A-dTG mice cardiomyocytes with or without anti-FLAG antibody and FITC-conjugated secondary antibody. Images were obtained with confocal at ×40 magnification. (D and E) Anti-FLAG, anti-NaV1.5, and anti-tubulin antibody immunoblots of cardiac homogenates showing FLAG epitope–tagged NaV1.5 expression in ventricle (D) and atrium (E) of single TG and dTG mice in the absence of doxycycline-impregnated food.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts